Never miss another update

Subscribe Today!

Angle PLC Announces Update on Lab Accreditation and Ovarian Study

First submissions made in relation to accreditation of ANGLE clinical laboratories Ovarian cancer study sample analysis slower than planned GUILDFORD, SURREY / ACCESSWIRE / January 13, 2022 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, provides an update on its plans for accreditation of its clinical laboratories and on its ovarian cancer study. First… Read More »Angle PLC Announces Update on Lab Accreditation and Ovarian Study

The post Angle PLC Announces Update on Lab Accreditation and Ovarian Study appeared on Stocks News Feed.

Posted in

The Markets Today